APP and Alzheimer disease: In addition, neuroinflammatory responses, such as microglial hyperactivation and increased expression levels of proinflammatory cytokines induced by β-amyloid deposits in an APP/PS1 transgenic mouse model of AD, were effectively suppressed by HJ administration [15].